Literature DB >> 21434583

A systematic compilation of reports published on opioid-related problems.

Matthew Butts1, Aminah Jatoi.   

Abstract

OBJECTIVES: This study examined the published literature on case reports of opioid-related problems to create a compendium that might lead to greater awareness and fewer such events.
METHODS: PubMed, Ovid, and the Cumulative Index to Nursing and Allied Health Literature were searched for case reports. A problem was defined as a healthcare provider's or patient's administration of an opioid in an unintended manner resulting in harm.
RESULTS: From more than 2200+ unique articles, 104 met the inclusion criteria. Fentanyl was most implicated. Problems included pump programming errors, patients' chewing transdermal patches, and pediatric overdosing with an oral droplet dispenser. Of 105 articles, 19 focused on patients with cancer and 86 on patients without cancer.
CONCLUSIONS: This compendium of opioid-related problems might generate further discussion about how best to reduce their number and morbidity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21434583     DOI: 10.5055/jom.2011.0047

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  4 in total

1.  Drug use evaluation of transdermal fentanyl in a tertiary hospital.

Authors:  Yi Ching Yuen; Mei Qi Wan; Jun Hao Tan; Noreen Chan
Journal:  Eur J Hosp Pharm       Date:  2016-02-05

2.  Asphyxiation with a fentanyl patch.

Authors:  Aaron S Mansfield; Aminah Jatoi
Journal:  Case Rep Oncol       Date:  2013-05-01

Review 3.  Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.

Authors:  Aleksandra Kotlinska-Lemieszek; Pål Klepstad; Dagny Faksvåg Haugen
Journal:  Drug Des Devel Ther       Date:  2015-09-16       Impact factor: 4.162

Review 4.  Drug Interactions With New Synthetic Opioids.

Authors:  Clara Pérez-Mañá; Esther Papaseit; Francina Fonseca; Adriana Farré; Marta Torrens; Magi Farré
Journal:  Front Pharmacol       Date:  2018-10-11       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.